Product Reports Resources Pricing Login Book a demo
VC profile

Vivo Capital

Venture capital

Private Equity, Venture Capital · Founded 1996 · Palo Alto, United States

Healthcare focused investment firm

Frank KungManaging Partner
Edgar G. EnglemanManaging Partner, Chief Scientific Advisor
Shan FuManaging Partner
Gaurav AggarwalManaging Partner
Michael ChangManaging Partner
Kevin DaiPartner
David LiuPartner
Hao DongManaging Director
01 · Biggest holdings

Vivo Capital’s biggest holdings

Dealroom has no ownership percentages for Vivo Capital, too few to size its stakes.

Request ownership data
02 · Exits

Vivo Capital’s biggest exits

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Vivo Capital’s transaction record.

$1.4B IPO · 2020
Entered Series B+Now $41BHealth
$373M IPO · 2015
Entered Series B+Now $17BHealth
$163M IPO · 2017
Entered Series ANow $10BHealth
$9.2B acquisition · 2026
Now $9.2BHealth
$391M IPO · 2018
Entered Series ANow $7.8BHealth
$5.9B IPO · 2020
Entered Series ANow $3.6BHealth
$691M IPO · 2017
Entered Series B+Now $5.3BHealth
$430M IPO · 2021
Entered Series B+Now $5.1BHealth
RemeGen
$4.3B IPO · 2020
Entered Series B+Now $4.3BHealth
$311M IPO · 2023
Entered Series B+Now $3.7BHealth
$626M IPO · 2016
Entered Series B+Now $3.6BHealth
$22M IPO · 2020
Entered Series B+Now $3.0BHealth
03 · Portfolio market map

Vivo Capital’s portfolio companies

The 60 highest-funded portfolio companies, of 131 tracked.

Lepu Biopharma
Health
$998M
Zai Lab
Health · Unicorn
$2.1B
Innocare
Health · Unicorn
$2.9B
Cidara Therapeutics
Health · Unicorn
$9.2B
Olema Oncology
Health
$550M
Crinetics Pharmaceuticals
Health · Unicorn
$7.8B
Surrozen
Health
$205M
RayzeBio
Health · Unicorn
$3.7B
SAB Biotherapeutics
Health
$257M
COMPASS Pathways
Health · Unicorn
$1.4B
OriCell Therapeutics
Health
$600M
Poseida Therapeutics
Health
$778M
Adarx Pharmaceuticals
Health
$800M
Harmony Biosciences
Health · Unicorn
$1.7B
Zenas BioPharma
Health · Unicorn
$1.6B
Aligos Therapeutics
Health
$8.4M
Alto Neuroscience
Health
$874M
ORIC Pharmaceuticals
Health · Unicorn
$1.1B
Gracell Biotechnologies
Health
$704M
Expedition Therapeutics
Health
$825M
Ventyx Biosciences
Health
$822M
Tebra
Health · Unicorn
$1.0B
Compass Therapeutics
Health
$216M
Full-Life Technologies
Health
$440M
Aadi Bioscience
Health
$271M
Achieve Life Science
Health
$668M
Serapha Bio
Health
$552M
IO Biotech
Health
Revolution Medicines
Health · Decacorn
$41B
Passage Bio
Health
Pulmocide
Health
$460M
Amyris Biotech
Chemicals
$532M
Sera Prognostics
Health
$36M
Selecta Biosciences
Health
$127M
Kinaset Therapeutics
Health
$412M
TRIA Beauty
Wellness Beauty
$30M
Instil Bio
Health
$60M
Serán Bioscience
Health
Avistone Pharmaceuticals
Health
$800M
Esco Lifesciences
Health
$800M
Vyne Therapeutics
Health
Nabriva Therapeutics
Health
Attralus
Health
$232M
Terns Pharmaceuticals
Health · Unicorn
$5.1B
SanegeneBio
Health
$440M
Adverum Biotechnologies
Health
$159M
Tourmaline Bio
Health
$991M
InBrace
Health
$408M
ALX Oncology
Health
$162M
SonoThera
Health
$500M
Ribon Therapeutics
Health
$325M
Regulus Therapeutics
Health
$501M
DBV Technologies
Health
$644M
Neocis
Health
$360M
Ruilongnuofu Medical Technology
Health
$600M
EpiBiologics
Health
$428M
Korsana Biosciences
Health
$600M
Revance Therapeutics
Health
$643M
BlossomHill Therapeutics
Health
$400M
Provivi
Food
$228M
04 · Portfolio founders

Where Vivo Capital’s portfolio founders come from

114 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States82
  2. China8
  3. United Kingdom8
  4. Switzerland3
  5. France2
  6. Australia1
  7. Canada1
  8. Denmark1
  9. Netherlands1
  10. Singapore1
UniversityCount
  1. University of California, Berkeley7
  2. Harvard University5
  3. Massachusetts Institute of Technology5
  4. Stanford University4
  5. Duke University3
  6. Princeton University3
  7. Stanford University Graduate School of Business3
  8. Columbia University2
  9. Harvard Business School2
  10. New York University2
Previous companyCount
  1. McKinsey & Company4
  2. Phase4 Partners3
  3. Alantos Pharmaceuticals2
  4. Bristol-Myers Squibb2
  5. Dana-Farber Cancer Institute2
  6. Estring2
  7. Genentech2
  8. MAKO Surgical2
  9. Massachusetts General Hospital2
  10. Merck & Co.2
Ecosystem map

Vivo Capital in the Palo Alto ecosystem

The Vivo Capital office with the hot startups, most funded companies and other investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →